Lemaitre Vascular earnings were $63.3M for the trailing 12 months ending Sep 30, 2026, with 17.7% growth year over year. The latest LMAT earnings report on Sep 30, 2026 announced Q3 2026 earnings of $15.0M, down 11.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LMAT reported annual earnings of $57.7M, with 31.1% growth.
LMAT past earnings growth
How has LMAT's earnings growth performed historically?
What were Lemaitre Vascular's earnings last quarter?
On LMAT's earnings call on Nov 4, 2026, Lemaitre Vascular (NASDAQ: LMAT) reported Q3 2026 earnings per share (EPS) of $0.66, up 14.29% year over year. Total LMAT earnings for the quarter were $15.02 million. In the same quarter last year, Lemaitre Vascular's earnings per share (EPS) was $0.77.
As of the last Lemaitre Vascular earnings report, Lemaitre Vascular is currently profitable. Lemaitre Vascular's net profit (also called net income) for the twelve months ending Sep 30, 2026 was $63.34 million, a 18.75% increase year over year.
What was LMAT's earnings growth in the past year?
As of Lemaitre Vascular's earnings date in Nov 4, 2026, Lemaitre Vascular's earnings has grown 17.72% year over year. This is 19.41 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 37.13%. LMAT earnings in the past year totalled $63.34 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.